Veco - VECO

Veeco Instruments (NASDAQ:VECO) Stock, Quote.Headers.trade-ideas

Veeco Instruments

Veeco Instruments Inc is a United States-based company that is principally engaged in designing, developing, and manufacturing thin-film process equipment, which is mainly used to produce electronic devices. The company's product categories by market consist of lighting, display, and power electronics; advanced packaging; MEMS and RF; scientific and industrial; and data storage. The lighting, display, and power electronics market accounts for over half of the total revenue. The company offers products and services in the United States; China; Europe, the Middle East, and Africa, or EMEA; and the rest of the world, with overseas markets contributing the majority of total revenue.

Micronimage_gallery_high_res_allen_texas-9

News

Price Target

Markets

Analyst Ratings

Trading Ideas

GRND

PANW

PAYX

SEDG

VECO

Micron To Rally Over 12%? Here Are 10 Top Analyst Forecasts For Thursday

Semiconductor.Shutterstock

Analyst Color

Small Cap

Tech

ENTG

NVDA

UCTT

Analyst Charles Shi issued buy ratings for ENTG ($150), BESI (160 pounds), VECO ($46), and UCTT ($56) as they outperform Wall Street expectations.

Four Small Cap Semiconductor Ideas To Look At During AI Boom

xr:d:DAFih-sWqhI:2,j:46865321670,t:23051015

Intraday Update

Movers

AFIB

AFRM

ALAB

AMRC

AMRK

AOSL

APEI

ARKO

BROS

CLOV

CPNG

CRCT

CRUS

DTCK

ELAN

FLYW

GMED

Hannon Armstrong Sustainable Infrastructure Capital

HASI

INOD

INSP

ISUN

LAZR

LYFT

MASI

MCRB

MXCT

MYGN

NIVF

PWSC

QLYS

REBN

RPTX

SATS

SHLS

SHOP

SIGA

SMLR

STAA

SWIM

TEVA

TIVC

TMCI

TOST

TRIP

TWLO

UBER

UPST

VLCN

Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

Veeco Instruments Inc

WIIM

AMAT

LRCX

MRVL

PSTG

SMCI

Shares of semiconductor and hardware stocks are trading lower amid a selloff in the sector, which has gained this year amid AI momentum.

ICHR

NTAP

Shares of hardware and data center companies are trading lower amid a selloff in chips and AI-related stocks.

Throughout the last three months, 6 analysts have evaluated Veeco Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VECO#NASDAQ">VECO</a>), offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $45.0, a high estimate of $55.00, and a low estimate of $35.00. This current average reflects an increase of 12.02% from the previous average price target of $40.17. 
<img src="https://www.benzinga.com/files/images/story/2024/1721052083_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Veeco Instruments. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Atif Malik</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$50.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Rick Schafer</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$55.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Rick Schafer</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$45.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Brian Lee</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$39.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Tom O'Malley</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$35.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Charles Shi</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$46.00</td>
<td>$43.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Veeco Instruments. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Veeco Instruments compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Veeco Instruments's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Veeco Instruments's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/VECO/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Veeco Instruments analyst ratings.</a>
<h2>Discovering Veeco Instruments: A Closer Look</h2>
Veeco Instruments Inc is a United States-based company that is principally engaged in designing, developing, and manufacturing thin-film process equipment, which is mainly used to produce electronic devices. The company's product categories by market consist of lighting, display, and power electronics; advanced packaging; MEMS and RF; scientific and industrial; and data storage. The lighting, display, and power electronics market accounts for over half of the total revenue. The company offers products and services in the United States; China; Europe, the Middle East, and Africa, or EMEA; and the rest of the world, with overseas markets contributing the majority of total revenue.
<h3>Financial Insights: Veeco Instruments</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Veeco Instruments's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2024, the company achieved a revenue growth rate of approximately 13.67%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: Veeco Instruments's net margin excels beyond industry benchmarks, reaching 12.82%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Veeco Instruments's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 3.29%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Veeco Instruments's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.82% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Veeco Instruments's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.45.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where Veeco Instruments Stands With Analysts

Citigroup analyst Atif Malik downgrades Veeco Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VECO#NASDAQ">VECO</a>) from Buy to Neutral and raises the price target from $45 to $50.

Downgrades

Citigroup Downgrades Veeco Instruments to Neutral, Raises Price Target to $50

Veeco Instruments's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VECO#NYSE">VECO</a>) short percent of float has fallen 3.64% since its last report. The company recently reported that it has 6.45 million shares sold short, which is 16.15% of all regular shares that are available for trading. Based on its trading volume, it would take traders 10.57 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Veeco Instruments Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1720553421_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Veeco Instruments has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Veeco Instruments's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Veeco Instruments's peer group average for short interest as a percentage of float is 6.31%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Looking Into Veeco Instruments's Recent Short Interest

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-ratings/">analyst ratings page</a>.
<ul>
<li>Stifel cut the price target for General Mills, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) from $77 to $70. Stifel analyst Matthew Smith maintained a Buy rating. General Mills shares fell 4.6% to close at $64.17 on Wednesday. <a href="https://www.benzinga.com/quote/GIS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Canaccord Genuity raised the price target for Hut 8 Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NASDAQ">HUT</a>) from $14 to $22. Canaccord Genuity analyst Joseph Vafi maintained a Buy rating. Hut 8 shares gained 4.8% to close at $15.32 on Wednesday. <a href="https://www.benzinga.com/quote/HUT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Oppenheimer boosted Veeco Instruments Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VECO#NASDAQ">VECO</a>) price target from $45 to $55. Oppenheimer analyst Rick Schafer maintained an Outperform rating. Veeco Instruments shares fell 1.1% to close at $45.83 on Wednesday. <a href="https://www.benzinga.com/quote/VECO/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird boosted the price target for Palo Alto Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) from $340 to $360. Baird analyst Shrenik Kothari maintained an Outperform rating. Palo Alto shares gained 0.8% to close at $325.26 on Wednesday. <a href="https://www.benzinga.com/quote/PANW/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Keybanc raised Micron Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) price target from $150 to $160. Keybanc analyst John Vinh maintained an Overweight rating. Micron shares gained 0.9% to close at $142.36 on Wednesday. <a href="https://www.benzinga.com/quote/MU/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Keefe, Bruyette &amp; Woods raised The Goldman Sachs Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) price target from $485 to $520. Keefe, Bruyette &amp; Woods analyst David Konrad maintained an Outperform rating. Goldman Sachs shares fell 0.3% to close at $455.86 on Wednesday. <a href="https://www.benzinga.com/quote/GS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JMP Securities raised the price target for Grindr Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRND#NYSE">GRND</a>) from $14 to $17. JMP Securities analyst Nicholas Jones maintained a Market Outperform rating. Grindr shares gained 15.3% to close at $11.82 on Wednesday. <a href="https://www.benzinga.com/quote/GRND/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Goldman Sachs cut SolarEdge Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) price target from $49 to $25. Goldman Sachs analyst Brian Lee maintained a Sell rating. SolarEdge shares fell 5.3% to close at $24.99 on Wednesday. <a href="https://www.benzinga.com/quote/SEDG/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities lowered TD SYNNEX Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNX#NYSE">SNX</a>) price target from $135 to $132. B of A Securities analyst Ruplu Bhattacharya maintained a Buy rating. TD SYNNEX shares fell 0.7% to close at $116.12 on Wednesday. <a href="https://www.benzinga.com/quote/SNX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities raised Paychex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) price target from $111 to $113. B of A Securities analyst Jason Kupferberg maintained an Underperform rating. Paychex shares fell 6.1% to close at $117.39 on Wednesday. <a href="https://www.benzinga.com/quote/PAYX/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/24/06/39500574/over-30m-bet-on-this-energy-stock-check-out-these-3-stocks-insiders-are-buying">Over $30M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying</a>

Analysts' ratings for Veeco Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VECO#NASDAQ">VECO</a>) over the last quarter vary from bullish to bearish, as provided by 5 analysts.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $44.0, a high estimate of $55.00, and a low estimate of $35.00. This upward trend is evident, with the current average reflecting a 12.24% increase from the previous average price target of $39.20.
<img src="https://www.benzinga.com/files/images/story/2024/1719493263_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
A comprehensive examination of how financial experts perceive Veeco Instruments is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Rick Schafer</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$55.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Rick Schafer</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$45.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Brian Lee</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$39.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Tom O'Malley</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$35.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Charles Shi</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$46.00</td>
<td>$43.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Veeco Instruments. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Veeco Instruments compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Veeco Instruments's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Veeco Instruments's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/VECO/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Veeco Instruments analyst ratings.</a>
<h2>Discovering Veeco Instruments: A Closer Look</h2>
Veeco Instruments Inc is a United States-based company that is principally engaged in designing, developing, and manufacturing thin-film process equipment, which is mainly used to produce electronic devices. The company's product categories by market consist of lighting, display, and power electronics; advanced packaging; MEMS and RF; scientific and industrial; and data storage. The lighting, display, and power electronics market accounts for over half of the total revenue. The company offers products and services in the United States; China; Europe, the Middle East, and Africa, or EMEA; and the rest of the world, with overseas markets contributing the majority of total revenue.
<h3>Financial Insights: Veeco Instruments</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Veeco Instruments displayed positive results in 3 months. As of 31 March, 2024, the company achieved a solid revenue growth rate of approximately 13.67%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.
Net Margin: Veeco Instruments's net margin excels beyond industry benchmarks, reaching 12.82%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Veeco Instruments's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.29% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Veeco Instruments's ROA stands out, surpassing industry averages. With an impressive ROA of 1.82%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.45, Veeco Instruments adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>How Are Analyst Ratings Determined?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Critical Insights From Veeco Instruments Analyst Ratings: What You Need To Know

Oppenheimer analyst Rick Schafer maintains Veeco Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VECO#NASDAQ">VECO</a>) with a Outperform and raises the price target from $45 to $55.

Oppenheimer Maintains Outperform on Veeco Instruments, Raises Price Target to $55

ACLS

ACMR

AVGO

NXPI

ONTO

QCOM

Shares of semiconductor stocks are trading higher amid possible sympathy with NVIDIA.

NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) kicked off the artificial intelligence and semiconductor booms, bringing along several semiconductor capital equipment companies. 
One analyst pointed to four small semicap companies, Entegris Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTG#NASDAQ">ENTG</a>), BE Semiconductor Industries NV (AMS: BESI), Veeco Instruments Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VECO#NASDAQ">VECO</a>) and Ultra Clean Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCTT#NASDAQ">UCTT</a>), as companies that could outperform <a href="https://www.benzinga.com/topic/wall-street">Wall Street expectations</a>.
The Semiconductor Analyst: Needham analyst Charles Shi issued Buy ratings for these company&#8217;s stock:
<ul>
<li>Entegris with a price target of $150.</li>
<li>BE Semiconductor Industries with a price target of 160 British pounds (@$204).</li>
<li>Veeco Instruments with a price target of $46.</li>
<li>Ultra Clean Holdings with a price target of $56.</li>
</ul>

Signal in the Noise: Shi believed it was more likely than not that AI-based valuations for semicap companies could be sustained. The analyst stated multiple expansions rather than earnings revisions were responsible for share price appreciation.
&#8220;Multiple expansion alone is not necessarily a source of concern. Historically in the early part of an upcycle, semicap stocks often appear to be &#8216;expensive,&#8217; but the strong upward revisions to EPS into a strong upcycle would naturally resolve the valuation issue,&#8221; Shi said. &#8220;In this cycle, however, with WFE likely growing at a slower pace than last cycle, we believe the amount of AI-driven multiple expansion in the past 12 months should concern semicap investors.&#8221;
The analyst also pointed to these four companies as long ideas.
ENTG: Entegris has seen downward EPS revisions and its multiple expansions have been outpaced by other semicap players.
&#8220;As all semiconductor segments have gone through a correction, we think EPS upward revision is coming, and the stock will look increasingly cheap,&#8221; Shi said. 
BESI: The analyst saw an opportunity in BE Semiconductor Industries which has similarly been beaten down.
&#8220;&#8230;we think the stock has been punished accordingly, with its P/E multiple expanding in line with large-cap stocks and EPS estimates resetting lower, which sets the stage for upside surprises,&#8221; Shi said. &#8220;Moreover, we think investors should not write off BESI&#8217;s AI story entirely, as the hybrid bonding story at Intel and TSMC remains solid.&#8221;
VECO: The analyst saw reason for optimism in Veeco Instruments amid low expectations for the company.
&#8220;We think the setup, i.e. strong execution and low expectation, is a positive for the stock. Moreover, we think VECO&#8217;s share gains in laser anneal and ion beam deposition on leading-edge foundry/logic and memory are good stories that will be reflected in upward EPS revisions over the next 12 to 18 months,&#8221; Shi said.
UCTT: Ultra Clean Holdings has seen both negative and positive revisions for future earnings. Shi believed the company&#8217;s comparatively low multiple expansion makes it a promising trade. The analyst sees UCTT as a &#8220;catchup&#8221; trade amid its better-perceived execution.
Price Actions at publication Tuesday:
<ul>
<li>ENTG traded at $132.99, up 0.53%</li>
<li>BESI traded at 141.75 pounds (@$181), up 1.50%</li>
<li>VECO traded at $41.37, down 0.39%</li>
<li>UCTT traded at $44.66, down 0.98%</li>
</ul>
Also Read: <a href="https://www.benzinga.com/top-stories/24/05/39011237/exclusive-nvidia-dow-jones-inclusion-a-matter-of-when-will-it-replace-intel">EXCLUSIVE: Nvidia Dow Jones Inclusion &#8216;A Matter Of When&#8217; — Will It Replace Intel?</a>
Photo: Shutterstock

Oppenheimer analyst Rick Schafer reiterates Veeco Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VECO#NASDAQ">VECO</a>) with a Outperform and raises the price target from $40 to $45.

Reiteration

Oppenheimer Reiterates Outperform on Veeco Instruments, Raises Price Target to $45

6 analysts have shared their evaluations of Veeco Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VECO#NASDAQ">VECO</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $39.67, with a high estimate of $46.00 and a low estimate of $35.00. Witnessing a positive shift, the current average has risen by 12.28% from the previous average price target of $35.33.
<img src="https://www.benzinga.com/files/images/story/2024/1715281261_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Veeco Instruments. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brian Lee</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$39.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Tom O'Malley</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$35.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Charles Shi</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$46.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Atif Malik</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$43.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Mark Miller</td>
<td>Benchmark</td>
<td>Raises</td>
<td>Buy</td>
<td>$40.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Brian Lee</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$35.00</td>
<td>$31.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Veeco Instruments. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Veeco Instruments compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Capture valuable insights into Veeco Instruments's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/VECO/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Veeco Instruments analyst ratings.</a>
<h2>All You Need to Know About Veeco Instruments</h2>
Veeco Instruments Inc is a United States-based company that is principally engaged in designing, developing, and manufacturing thin-film process equipment, which is mainly used to produce electronic devices. The company's product categories by market consist of lighting, display, and power electronics; advanced packaging; MEMS and RF; scientific and industrial; and data storage. The lighting, display, and power electronics market accounts for over half of the total revenue. The company offers products and services in the United States; China; Europe, the Middle East, and Africa, or EMEA; and the rest of the world, with overseas markets contributing the majority of total revenue.
<h3>Breaking Down Veeco Instruments's Financial Performance</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Veeco Instruments's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 13.09% as of 31 December, 2023, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.
Net Margin: Veeco Instruments's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 12.44%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Veeco Instruments's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.29% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Veeco Instruments's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.75% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Veeco Instruments's debt-to-equity ratio is below the industry average. With a ratio of 0.46, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Analyst Ratings: What Are They?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into Veeco Instruments Stock: Analyst Perspectives (6 Ratings)

Goldman Sachs analyst Brian Lee maintains Veeco Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VECO#NASDAQ">VECO</a>) with a Neutral and raises the price target from $35 to $39.

Goldman Sachs Maintains Neutral on Veeco Instruments, Raises Price Target to $39

Barclays analyst Tom O'Malley maintains Veeco Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VECO#NASDAQ">VECO</a>) with a Equal-Weight and raises the price target from $33 to $35.

Barclays Maintains Equal-Weight on Veeco Instruments, Raises Price Target to $35

Shares of Upstart Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>) fell sharply during Wednesday's session after the company reported first-quarter financial results and issued second-quarter revenue <a href="https://www.benzinga.com/news/earnings/24/05/38682848/upstart-q1-earnings-revenue-beat-eps-beat-targeting-positive-ebitda-in-2024-and-more">guidance below estimates</a>.
Upstart reported first-quarter revenue of $128 million, which beat the consensus estimate of $124.867 million, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Upstart expects second-quarter revenue of approximately $125 million versus estimates of $140.83 million. The company anticipates a second-quarter adjusted EBITDA loss of approximately $25 million.
Upstart shares dipped 10.3% to $21.96 on Wednesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Reborn Coffee, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REBN#NASDAQ">REBN</a>) shares jumped 132.9% to $4.0297 after the company announced a significant expansion into the China market through a strategic Master License Agreement with IAID Co.</li>
<li>iSun, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISUN#NASDAQ">ISUN</a>) gained 49% to $0.1966.</li>
<li>NewGenIvf Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) jumped 36.4% to $1.48.</li>
<li>Tivic Health Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) rose 34% to $1.4099.</li>
<li>Innodata Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INOD#NASDAQ">INOD</a>) shares gained 31.5% to $8.86 after the company reported a year-over-year increase in first-quarter financial results.</li>
<li>Cricut, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRCT#NASDAQ">CRCT</a>) gained 31% to $7.25 after the company reported better-than-expected first-quarter GAAP EPS results.</li>
<li>MaxCyte, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MXCT#NASDAQ">MXCT</a>) rose 27.6% to $5.01 following upbeat quarterly results.</li>
<li>Ameresco, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRC#NASDAQ">AMRC</a>) gained 27.6% to $28.47 following strong quarterly results.</li>
<li>Davis Commodities Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTCK#NASDAQ">DTCK</a>) rose 26.8% to $1.5580</li>
<li>Elanco Animal Health Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELAN#NYSE">ELAN</a>) surged 26.5% to $17.11 following strong quarterly earnings.</li>
<li>American Public Education, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APEI#NASDAQ">APEI</a>) rose 23.3% to $18.71 following upbeat quarterly results.</li>
<li>Globus Medical, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>) gained 23.3% to $63.35 after the company reported better-than-expected first-quarter financial results and raised its FY24 guidance.</li>
<li>Kyndryl Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KD#NYSE">KD</a>) jumped 21.6% to $25.25 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>PowerSchool Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PWSC#NYSE">PWSC</a>) gained 21.2% to $20.17 following a report suggesting Bain is pursuing a takeover of the company.</li>
<li>Myriad Genetics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYGN#NASDAQ">MYGN</a>) rose 21.1% to $24.02 following better-than-expected first-quarter earnings.</li>
<li>Arko Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKO#NYSE">ARKO</a>) gained 20.3% to $5.15 following first-quarter earnings.</li>
<li>Latham Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWIM#NASDAQ">SWIM</a>) gained 19% to $3.5609 following strong first-quarter earnings.</li>
<li>Hyster-Yale Materials Handling, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HY#NYSE">HY</a>) surged 18.2% to $69.74 following UPBEAT first-quarter earnings.</li>
<li>Alpha and Omega Semiconductor Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AOSL#NASDAQ">AOSL</a>) jumped 17.7% to $26.22 after reporting strong quarterly results.</li>
<li>Neo-Concept International Group Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCI#NASDAQ">NCI</a>) gained 17.2% to $1.1529 after declining over 6% on Tuesday.</li>
<li>Oddity Tech Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODD#NASDAQ">ODD</a>) gained 15.8% to $36.19 after the company reported better-than-expected first-quarter financial results and issued FY24 EPS guidance above estimates.</li>
<li>Dutch Bros Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BROS#NYSE">BROS</a>) climbed 15.5% to $32.82 after the company reported better-than-expected first-quarter financial results and raised its FY24 revenue guidance.</li>
<li>Louisiana-Pacific Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPX#NYSE">LPX</a>) gained 15% to $83.93 following better-than-expected first-quarter financial results.</li>
<li>RingCentral, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNG#NYSE">RNG</a>) rose 14.8% to $34.42 after the company reported better-than-expected first-quarter financial results and raised its FY24 guidance.</li>
<li>Luminar Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) rose 14.5% to $1.89 as the company posted a narrower-than-expected quarterly loss.</li>
<li>Toast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>) gained 14.2% to $27.09 after the company reported better-than-expected quarterly sales results.</li>
<li>Hannon Armstrong Sustainable Infrastructure Capital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HASI#NASDAQ">HASI</a>) gained 13.9% to $29.84 following upbeat earnings.</li>
<li>Teva Pharmaceutical Industries Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>) rose 13% to $15.75 after the company reported mixed first quarter financial results.</li>
<li>Repare Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPTX#NASDAQ">RPTX</a>) gained 11.7% to $3.6650 after the company posted better-than-expected results for its first quarter.</li>
<li>Vistra Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) gained 10.1% to $90.01 after the company reported first quarter financial results.</li>
<li>Cirrus Logic, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRUS#NASDAQ">CRUS</a>) jumped 9.6% to $99.93 as the company posted better-than-expected results for its fourth quarter.</li>
<li>Clover Health Investments, Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLOV#NASDAQ">CLOV</a>) shares gained 9.5% to $0.81 after the company reported better than expected first-quarter financial results.</li>
<li>Lyft, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) gained 8.8% to $18.08 following better-than-expected first-quarter results.</li>
<li>Veeco Instruments Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VECO#NASDAQ">VECO</a>) rose 6.9% to $40.08 following upbeat results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Treace Medical Concepts, Inc.. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMCI#NASDAQ">TMCI</a>) shares dipped 60.8% to $4.3650 after the company reported first-quarter financial results and issued FY24 revenue guidance below estimates.</li>
<li>DoubleVerify Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DV#NYSE">DV</a>) fell 38.5% to $18.79 after the company reported first-quarter financial results.</li>
<li>Inspire Medical Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INSP#NYSE">INSP</a>) fell 34.3% to $161.35 following first-quarter results.</li>
<li>Definitive Healthcare Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DH#NASDAQ">DH</a>) dipped 32.2% to $4.9150 after the company reported worse-than-expected first-quarter sales results.</li>
<li>Seres Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRB#NASDAQ">MCRB</a>) fell 31.1% to $0.7653 following quarterly results.</li>
<li>Tripadvisor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIP#NASDAQ">TRIP</a>) fell 28.4% to $18.24 after Liberty Tripadvisor and the Special Committee ceased discussions with third parties with respect to a potential transaction.</li>
<li>ZoomInfo Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZI#NASDAQ">ZI</a>) shares fell 25.2% to $11.98 after the company reported first-quarter financial results and issued second-quarter guidance below estimates.</li>
<li>LegalZoom.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZ#NASDAQ">LZ</a>) dipped 23.3% to $9.35 after the company reported worse-than-expected first-quarter financial results and issued second-quarter revenue guidance below estimates.</li>
<li>Semler Scientific, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMLR#NASDAQ">SMLR</a>) fell 22.7% to $21.78 after the company reported worse-than-expected first-quarter financial results.</li>
<li>Grocery Outlet Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GO#NASDAQ">GO</a>) dipped 22.2% to $20.17 after the company reported worse-than-expected first-quarter adjusted EPS results.</li>
<li>Flywire Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYW#NASDAQ">FLYW</a>) shares declined 21.7% to $16.08 after the company reported worse-than-expected first-quarter EPS results and issued second-quarter revenue guidance below estimates.</li>
<li>SIGA Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIGA#NASDAQ">SIGA</a>) dipped 20.6% to $8.31 following first-quarter results.</li>
<li>Shopify Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) fell 19.8% to $61.76 following first-quarter earnings..</li>
<li>Rapid7, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) dipped 18.6% to $37.26 following first-quarter earnings..</li>
<li>Acutus Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFIB#NASDAQ">AFIB</a>) fell 17.1% to $0.1020 after jumping 15% on Tuesday. Nasdaq, last week, notified the company that it has not regained compliance with listing rule 5550(a)(2).</li>
<li>Shoals Technologies Group, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) shares fell 14.1% to $7.56 after the company reported worse-than-expected first-quarter sales results.</li>
<li>Masimo Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASI#NASDAQ">MASI</a>) fell 13.8% to $117.23 following first-quarter earnings. The company&#8217;s second-quarter guidance midpoint was below consensus estimates.</li>
<li>EchoStar Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATS#NASDAQ">SATS</a>) dipped 13.6% to $14.99 following worse-than-expected first-quarter financial results.</li>
<li>STAAR Surgical Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAA#NASDAQ">STAA</a>) dipped 11.8% to $41.10 following quarterly results.</li>
<li>Volcon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLCN#NASDAQ">VLCN</a>) shares declined 11.8% to $0.26 after the company reported a year-over-year decrease in first-quarter sales results.</li>
<li>Qualys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QLYS#NASDAQ">QLYS</a>) fell 10.1% to $149.21 after the company reported first-quarter earnings and issued second-quarter revenue guidance below estimates.</li>
<li>Affirm Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) fell 9.1% to $31.74 following third-quarter earnings.</li>
<li>Uber Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) dipped 8.6% to $64.40. Uber posted weaker-than-expected fiscal first-quarter financial results.</li>
<li>Coupang, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPNG#NYSE">CPNG</a>) fell 7.8% to $21.78 after the company reported mixed first-quarter financial results.</li>
<li>Astera Labs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) shares declined 6.3% to $71.37 following first-quarter results.</li>
<li>Centrus Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEU#NYSE">LEU</a>) shares declined 6.2% to $41.56 following first-quarter results.</li>
<li>A-Mark Precious Metals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRK#NASDAQ">AMRK</a>) shares fell 5.5% to $38.14 following fiscal third quarter 2024 results.</li>
<li>Twilio Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>) shares fell 5.5% to $59.86 following first-quarter results.</li>
<li>OPKO Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPK#NASDAQ">OPK</a>) shares fell 5.4% to $1.23 after the company reported worse-than-expected first-quarter financial results.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/05/38702433/airbnb-gears-up-for-q1-print-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Airbnb Gears Up For Q1 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a>

Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Veeco shares are trading higher after the company reported better-than-expected Q1 financial results.

U.S. stocks were mixed, with the Dow Jones gaining around 70 points on Wednesday.
Shares of Louisiana-Pacific Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPX#NYSE">LPX</a>) rose sharply during Wednesday's session  following better-than-expected <a href="https://www.benzinga.com/news/earnings/24/05/38701468/building-success-louisiana-pacific-shatters-expectations-shares-surge-on-solid-q1-performance-raise">first-quarter financial results</a>.
LPX reported net sales growth of 24% year-over-year to $724 million, beating the consensus of $688.85 million.
Louisiana-Pacific shares climbed 15% to $83.93 on Wednesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Cricut, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRCT#NASDAQ">CRCT</a>) shares surged 31% to $7.25 after the company reported better-than-expected first-quarter GAAP EPS results.</li>
<li>MaxCyte, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MXCT#NASDAQ">MXCT</a>) jumped 27.6% to $5.01 following upbeat quarterly results.</li>
<li>Ameresco, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRC#NASDAQ">AMRC</a>) climbed 27.6% to $28.47 following strong quarterly results.</li>
<li>Elanco Animal Health Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELAN#NYSE">ELAN</a>) gained 26.5% to $17.11 following strong quarterly earnings.</li>
<li>American Public Education, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APEI#NASDAQ">APEI</a>) gained 23.3% to $18.71 following upbeat quarterly results.</li>
<li>Globus Medical, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>) rose 23.3% to $63.35 after the company reported better-than-expected first-quarter financial results and raised its FY24 guidance.</li>
<li>Kyndryl Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KD#NYSE">KD</a>) gained 21.6% to $25.25 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>PowerSchool Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PWSC#NYSE">PWSC</a>) rose 21.2% to $20.17 following a report suggesting Bain is pursuing a takeover of the company.</li>
<li>Myriad Genetics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYGN#NASDAQ">MYGN</a>) climbed 21.1% to $24.02 following better-than-expected first-quarter earnings.</li>
<li>Arko Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKO#NYSE">ARKO</a>) gained 20.3% to $5.15 following first-quarter earnings.</li>
<li>Latham Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWIM#NASDAQ">SWIM</a>) rose 19% to $3.5609 following strong first-quarter earnings.</li>
<li>Hyster-Yale Materials Handling, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HY#NYSE">HY</a>) gained 18.2% to $69.74 following UPBEAT first-quarter earnings.</li>
<li>Alpha and Omega Semiconductor Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AOSL#NASDAQ">AOSL</a>) surged 17.7% to $26.22 after reporting strong quarterly results.</li>
<li>Oddity Tech Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODD#NASDAQ">ODD</a>) rose 15.8% to $36.19 after the company reported better-than-expected first-quarter financial results and issued FY24 EPS guidance above estimates.</li>
<li>Dutch Bros Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BROS#NYSE">BROS</a>) gained 15.5% to $32.82 after the company reported better-than-expected first-quarter financial results and raised its FY24 revenue guidance.</li>
<li>RingCentral, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNG#NYSE">RNG</a>) gained 14.8% to $34.42 after the company reported better-than-expected first-quarter financial results and raised its FY24 guidance.</li>
<li>Luminar Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) gained 14.5% to $1.89 as the company posted a narrower-than-expected quarterly loss.</li>
<li>Toast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>) rose 14.2% to $27.09 after the company reported better-than-expected quarterly sales results.</li>
<li>Hannon Armstrong Sustainable Infrastructure Capital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HASI#NASDAQ">HASI</a>) surged 13.9% to $29.84 following upbeat earnings.</li>
<li>Denali Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNLI#NASDAQ">DNLI</a>) rose 13.2% to $19.07 following a narrower-than-expected quarterly loss.</li>
<li>Teva Pharmaceutical Industries Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>) gained 13% to $15.75 after the company reported mixed first quarter financial results.</li>
<li>Vistra Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) climbed 10.1% to $90.01 after the company reported first quarter financial results.</li>
<li>Cirrus Logic, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRUS#NASDAQ">CRUS</a>) gained 9.6% to $99.93 as the company posted better-than-expected results for its fourth quarter.</li>
<li>Lotus Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOT#NASDAQ">LOT</a>) gained 9.1% to $8.51.</li>
<li>Lyft, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) rose 8.8% to $18.08 following better-than-expected first-quarter results.</li>
<li>Griffon Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GFF#NYSE">GFF</a>) surged 8.6% to $73.64 following upbeat second-quarter results.</li>
<li>Grand Canyon Education, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOPE#NASDAQ">LOPE</a>) rose 7.7% to $150.62 following upbeat quarterly results.</li>
<li>Confluent, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>) gained 7.7% to $30.00 after the company reported better-than-expected quarterly financial results and raised its FY24 guidance above estimates.</li>
<li>Veeco Instruments Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VECO#NASDAQ">VECO</a>) gained 6.9% to $40.08 following upbeat results.</li>
<li>International Seaways, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INSW#NYSE">INSW</a>) rose 6.3% to $60.21 after posting upbeat earnings.</li>
<li>LCI Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCII#NASDAQ">LCII</a>) surged 6.2% to $111.48 following strong quarterly results.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/05/38701877/jim-cramer-says-he-is-struggling-with-tesla-likes-this-industrial-giant">Jim Cramer Says He Is &#8216;Struggling&#8217; With Tesla, Likes This Industrial Giant</a>

CFLT

DNLI

INSW

LCII

LOPE

Louisiana-Pacific Posts Upbeat Results, Joins Cricut, Elanco Animal, American Public Education And Other Big Stocks Moving Higher On Wednesday

Needham analyst Charles Shi maintains Veeco Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VECO#NASDAQ">VECO</a>) with a Buy and raises the price target from $43 to $46.

Needham Maintains Buy on Veeco Instruments, Raises Price Target to $46

Guidance

Veeco Instruments Expects Q2 Revenue Of $165M-$185M (Est $174.944M), Adj EPS Of $0.38-$0.48 (Est $0.43)

Veeco Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VECO#NASDAQ">VECO</a>) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.41 by 9.76 percent. This is a 50 percent increase over earnings of $0.30 per share from the same period last year. The company reported quarterly sales of $174.484 million which beat the analyst consensus estimate of $170.548 million by 2.31 percent. This is a 13.67 percent increase over sales of $153.504 million the same period last year.

Earnings

Earnings Beats

Veeco Instruments Q1 2024 Adj EPS $0.45 Beats $0.41 Estimate, Sales $174.484M Beat $170.548M Estimate

Applied Materials, Lam Research in focus as Citi expects chip spending to rise

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Business leaders often talk about thinking big. But when it comes to nanotech stocks, the future is all about focusing on the small things.



According to the European Commission, nanotechnology represents a <a href="https://ec.europa.eu/health/scientific_committees/opinions_layman/en/nanotechnologies/l-2/1-introduction.htm#:~:text=Nanotechnology%20refers%20to%20the%20branch,of%20a%20millimetre)%20or%20less.">scientific and engineering discipline</a> that&rsquo;s &ldquo;devoted to designing, producing, and using structures, devices, and systems by manipulating atoms and molecules at nanoscale.&rdquo; Nanoscales refer to having one or more dimensions of the order of 100 nanometers (or 100 millionth of a millimeter).



Stated differently, nanotechnology centers on density; that is, being able to pack various capacities in an extremely small space. According to Grand View Research, this field features enormous potential and applications across various scientific domains, including chemistry, biomedical science, mechanics and materials science.



In terms of hard numbers, the global nanotech market <a href="https://www.grandviewresearch.com/industry-analysis/nanotechnology-market-report">reached a valuation of $3.69 billion in 2022</a>. By 2030, the ecosystem could be worth $36.85 billion, or a compound annual growth rate (CAGR) of 33.1%. With projected expansion like that, it pays to at least consider these nanotech stocks.



<h2>Veeco Instruments (VECO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/semiconductor1600c-300x169.jpg" alt="AI. Circuit board. Technology background. Central Computer Processors CPU concept. Motherboard digital chip. Tech science background. Integrated communication processor. 3D illustration representing semiconductor stocks. Semiconductors Stocks to Sell"><div>Source: Shutterstock</div></div>Based in Plainview, New York, Veeco Instruments (NASDAQ:<a href="https://investorplace.com/stock-quotes/veco-stock-quote/">VECO</a>) falls under the semiconductor sector; specifically, it works in the field of semiconductor equipment and materials. Per its public profile, Veeco focuses on thin film process equipment primarily to develop electronic devices. It&rsquo;s one of the top nanotech stocks thanks to the microscopic precision needed to develop these high-performance semiconductor devices.



To be sure, VECO stock has already enjoyed a robust performance so far this year. However, it&rsquo;s one of the small middle-capitalization plays, making it an intriguing idea for the long haul. One aspect that&rsquo;s impressive is its financial performance. Between the second quarter of 2023 to Q1 2024, the company&rsquo;s average earnings per share reached 46.3 cents. This translated to an earnings surprise of 23.6%.



During the trailing 12 months, Veeco did incur a net loss of $17.25 million or 36 cents per share. However, revenue hit $687.41 million. Overall, for fiscal 2024, covering experts anticipate a recovery, with EPS possibly rising 7.1% to hit $1.81. Further, sales could increase by 8% to hit $719.47 million. Therefore, VECO makes a solid case for nanotech stocks to consider.



<h2>Bruker (BRKR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/06/brkr-1600-300x169.jpg" alt="Bruker sign and logo at office of manufacturer of scientific instruments for molecular and materials research company"><div>Source: Michael Vi / Shutterstock.com</div></div>Headquartered in Billerica, Massachusetts, Bruker (NASDAQ:<a href="https://investorplace.com/stock-quotes/brkr-stock-quote/">BRKR</a>) falls under the healthcare sector, specifically dealing with medical devices. <a href="https://stockanalysis.com/stocks/brkr/company/">Per its corporate profile</a>, Bruker with its subsidiaries develops, manufactures and distributes scientific instruments, along with analytical and diagnostic solutions. Many of its tools &ndash; such as electronic microscopes &ndash; are vital for nanotechnology research and development.



Financially, BRKR stock makes a case for top nanotech stocks thanks to its consistency of performance. Between Q2 2023 to Q1 2024, the company&rsquo;s average EPS reached 64.3 cents. This translated to an average earnings surprise of 13.63%. Notably, the company beat all of the past four of its bottom-line profitability targets.



During the TTM period, Bruker posted net income of $401.6 million, translating to earnings of $2.73 per share. Revenue during this cycle reached $3 billion. For fiscal 2024, analysts anticipate on average a slight dip in EPS to $2.66. However, revenue could see a 14% rise from the prior year to hit $3.38 billion.



In fiscal 2025, EPS could move up 18% to land at $3.14. On the top line, revenue may see an 8.6% lift to reach $3.67 billion. All in all, BRKR makes another solid case for nanotech stocks.



<h2>Luna Innovations (LUNA)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/06/shutterstock_1926453779-300x169.png" alt="top Tech stocks to watch : Double exposure of man's hands holding and using a phone and financial graph drawing. tech stocks"><div>Source: Peshkova / Shutterstock</div></div>If you want to dive into the extremely speculative side of the sector, consider Luna Innovations (NASDAQ:<a href="https://investorplace.com/stock-quotes/luna-stock-quote/">LUNA</a>). Falling under the technology sphere, Luna is involved in the scientific and technical instruments industry. <a href="https://stockanalysis.com/stocks/luna/company/">According to its profile</a>, Luna provides fiber optic tests, measurements and control products worldwide. Its advanced optical solutions feature relevance for entities seeking nanoscale measurements and monitoring.



To be fair, Luna&rsquo;s speculative nature shows when it comes to its earnings performances. It hasn&rsquo;t been hit or miss. Rather, it&rsquo;s been more miss or not miss. However, the company does enjoy generally positive analyst coverage that goes back to November of last year. The latest call from Needham&rsquo;s Alex Henderson is a &ldquo;buy&rdquo; with an $8 price target, which is massive.



During the TTM period, Luna posted a net loss of $1.12 million, or three cents per share. Revenue in the cycle landed at $116.61 million. Now, due to <a href="https://cardinalnews.org/2024/04/19/roanoke-based-luna-innovations-says-more-financial-statements-are-unreliable/">accounting errors</a>, some of the numbers that have been broadcasted are not fully reliable. Obviously, that&rsquo;s a concern.



Still, if you want to take the risk, analysts see fiscal 2024 revenue to rise to $165.24 million. That&rsquo;s a sizable leap from <a href="https://www.gurufocus.com/stock/LUNA/financials?search=luna">prior top-line performances</a>, making it a high-leverage gamble among nanotech stocks.



On the date of publication, Josh Enomoto did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<div>A former senior business analyst for Sony Electronics, Josh Enomoto has helped broker major contracts with Fortune Global 500 companies. Over the past several years, he has delivered unique, critical insights for the investment markets, as well as various other industries including legal, construction management, and healthcare. Tweet him at @EnomotoMedia.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/06/rags-to-riches-3-nanotech-stocks-that-could-make-early-investors-rich/">Rags to Riches: 3 Nanotech Stocks That Could Make Early Investors Rich</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Rags to Riches: 3 Nanotech Stocks That Could Make Early Investors Rich

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Advancements in semiconductor manufacturing, medical applications and materials science are projected to expand the nanotech market significantly in 2024. This backdrop forms the backdrop for my three nanotech stocks to buy.



Key growth drivers include <a href="https://www.grandviewresearch.com/industry-analysis/nanotechnology-market-report">advancements</a> in nanoelectronics, nanomedicine and nanomaterials. The healthcare sector, in particular, is a significant beneficiary. It can leverage nanotechnology for improved diagnostics, targeted drug delivery and innovative treatment solutions&#8203;.



Regional growth is prominent in North America, fueled by substantial R&amp;D investments and solid governmental support through initiatives like the National Nanotechnology Initiative. Asia-Pacific is rapidly expanding due to competitive manufacturing advantages and rising investments in nanotech research, particularly in countries like China, Japan and India.



Integrating nanotechnology with emerging technologies such as artificial intelligence and the Internet of Things (IoT) will broaden its application scope further.



So here are three of the best nanotech stocks for investors to buy.



<h2>Applied Materials (AMAT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/11/amat-stock-300x169.jpg" alt="Applied Materials (AMAT) company sign outside office"><div>Source: michelmond / Shutterstock.com</div></div>Applied Materials (NASDAQ:<a href="https://investorplace.com/stock-quotes/amat-stock-quote/">AMAT</a>) is a leader in nanomanufacturing technology, providing equipment, services and software for producing semiconductor chips and advanced displays.<a href="https://investorplace.com/cryptocurrency//"></a>



The company&rsquo;s <a href="https://ir.appliedmaterials.com/news-releases/news-release-details/applied-materials-announces-first-quarter-2024-results">reported Q1 2024 revenue</a> of $6.71 billion was flat compared to the same quarter last year. However, its GAAP gross margin improved 1.1 percentage points year-over-year to 47.8%. Its GAAP operating margin increased slightly by 0.1 points to 29.3%.&nbsp;



During the quarter, the company generated $2.33 billion in cash from operations. Applied Materials also returned $966 million to shareholders, including $700 million in share repurchases and $266 million in dividends. Looking ahead to Q2 2024, the company expects revenue of approximately $6.50 billion, plus or minus $400 million, and non-GAAP diluted EPS in the range of $1.79 to $2.15.



Thanks to these strong results, AMAT is one of the top nanotech stocks to consider.



<h2>Thermo Fisher Scientific (TMO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/10/tmo-stock-1-300x169.jpg" alt="A Thermo Fisher Scientific sign out front of an office in Silicon Valley, California."><div>Source: Michael Vi / Shutterstock.com</div></div>Thermo Fisher Scientific (NYSE:<a href="https://investorplace.com/stock-quotes/tmo-stock-quote/">TMO</a>) is at the forefront of nanotechnology research and development. It offers a wide range of products and services for nanoscale analysis and manufacturing.



The <a href="https://ir.thermofisher.com/investors/news-events/news/news-details/2024/Thermo-Fisher-Scientific-Reports-First-Quarter-2024-Results/">reported Q1 2024 revenue</a> of $10.34 billion is a decline of 3% compared to the same quarter last year. Organic revenue was 4% lower, while Core organic revenue growth declined 3%. GAAP diluted EPS increased 4% to $3.46, and adjusted EPS grew 2% to $5.11.



Thermo Fisher also raised its full-year 2024 revenue and adjusted EPS guidance to reflect stronger operational performance. The company now expects revenue from $42.3 to $43.3 billion, from the previous guidance of $42.1 to $43.3 billion.



Furthermore, analysts have <a href="https://stockanalysis.com/stocks/tmo/forecast/">some positive expectations</a> for TMO stock. In 2024, the average revenue forecast is $43.42 billion. This represents a 1.32% increase from the previous year&rsquo;s revenue of $42.86 billion. The revenue is expected to continue growing, with an average forecast of $46.55 billion in 2025, $49.94 billion in 2026, $52.74 billion in 2027 and $55.27 billion in 2028.



<h2>Veeco Instruments (VECO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/01/nano1600-300x169.jpg" alt="Cryptocurrency stock image"><div>Source: Lucio Libanori / Shutterstock.com</div></div>Veeco Instruments (NASDAQ:<a href="https://investorplace.com/stock-quotes/veco-stock-quote/">VECO</a>) specializes in advanced thin-film equipment and technologies for the production of nanomaterials, semiconductors and other high-tech applications.



Its reported <a href="https://ir.veeco.com/news-and-events/news-details/2024/Veeco-Reports-First-Quarter-2024-Financial-Results/default.aspx">Q1 2024 revenue</a> of $174.5 million was an increase compared to $153.5 million in the same period last year. GAAP net income was $21.9 million, or $0.37 per diluted share, compared to $8.7 million, or $0.17 per diluted share, in Q1 2023. The company&rsquo;s GAAP operating income increased to $22 million. Non-GAAP operating income grew to $29.4 million from $20.4 million in Q1 2023.



Analysts also collectively have <a href="https://stockanalysis.com/stocks/veco/forecast/">bullish expectations</a> for VECO. Revenue is expected to increase 10.12% to $733.86 million in 2024 from $666.44 million in the previous year. Revenue is projected to grow in 2025, with an average forecast of $808.17 million, representing a 10.13% increase from 2024. EPS is expected to rebound from -$0.56 in 2023 to $1.84 in 2024. For 2025, the average EPS forecast is $2.16, a 17.35% increase from 2024.



On the date of publication, Matthew Farley did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed are those of the writer, subject to the InvestorPlace.com <a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.
<div>Matthew started writing coverage of the financial markets during the crypto boom of 2017 and was also a team member of several fintech startups. He then started writing about Australian and U.S. equities for various publications. His work has appeared in MarketBeat, FXStreet, Cryptoslate, Seeking Alpha, and the New Scientist magazine, among others.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/07/3-nanotech-stocks-that-could-make-your-grandchildren-rich/">3 Nanotech Stocks That Could Make Your Grandchildren Rich</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

3 Nanotech Stocks That Could Make Your Grandchildren Rich

Oppenheimer's best 'SMID-cap' ideas for 2024

Oppenheimer's top SMID ideas within high-growth themes

KLA Corp. in spotlight as Citi make top pick; firm also moves Teradyne higher

Riverwater Sustainable Value Strategy Q2 2024 Commentary

Riverwater Micro Opportunities Strategy Q2 2024 Commentary

Veeco Instruments: A Key Supplier Of The AI Arms Race

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Given the expanding size of the nanotechnology industry, buying nanotechnology stocks with a very low-risk profile is possible.



Electronics is one of the most important sectors that applies nanotechnology. Technologies like <a href="https://www.startus-insights.com/innovators-guide/nanotechnology-trends/">nanoscale</a> semiconductors and nanorobots are improving the efficiency and size of electronic elements. This sector is expanding further due to the emergence of nanotechnology, which enhances the creation of better and more effective electronic gadgets.&nbsp;



Current nanotechnology&nbsp;<a href="https://www.grandviewresearch.com/industry-analysis/nanotechnology-market-report" target="_blank">market</a>&nbsp;estimates indicate North America holds the largest share due to high research and development investments and the geographical location of numerous technological centers. At the same time, the Asia-Pacific region is forecast to grow at the fastest pace. This is owing to investments in the energy and manufacturing industries. China, India and Japan are the key players in producing large-scale nanomaterials in this region.



Here are three of the best nanotechnology stocks with the best risk profiles.



<h2>Thermo Fisher Scientific (TMO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/10/tmo-stock-1-300x169.jpg" alt="A Thermo Fisher Scientific sign out front of an office in Silicon Valley, California."><div>Source: Michael Vi / Shutterstock.com</div></div>As an investor, I like Thermo Fisher Scientific (NYSE:<a href="https://investorplace.com/stock-quotes/tmo-stock-quote/">TMO</a>) for its low-risk approach to nanotechnology.&nbsp;



The latest <a href="https://ir.thermofisher.com/investors/news-events/news/news-details/2023/Thermo-Fisher-Scientific-to-Acquire-Olink-a-Leader-in-Next-Generation-Proteomics/default.aspx">acquisition</a> of Olink by TMO improves the company&rsquo;s proteomics solutions, especially in mass spectrometry. Also, the company&rsquo;s collaboration with Bayer AG to develop next-generation&nbsp;<a href="https://www.bayer.com/media/en-us/bayer-and-thermo-fisher-scientific-collaborate-to-increase-patient-access-to-precision-cancer-medicines/" target="_blank">sequencing</a>&nbsp;is evidence of its continued innovation.&nbsp;



China is another region that will benefit from TMO due to the country&rsquo;s stimulus program for capital&nbsp;<a href="https://www.bioprocessintl.com/therapeutic-class/bioprocess-industry-eyes-china-s-stimulus-program-amid-funding-woes" target="_blank">equipment</a>. TMO&rsquo;s strengths, operational diversity and product development make it a low-risk investment in the Nanotech sector.



Meanwhile, I think that TMO is also low risk from a <a href="https://stockanalysis.com/stocks/tmo/statistics/">valuation</a> perspective. Its projected forward earnings of 25x are substantially lower than its trailing earnings of 36x. Analysts, therefore, see great potential in the company to continue growing its bottom line, and I expect this trend to continue into the future. This makes TMO one of those nanotechnology stocks to consider.



<h2>Veeco Instruments (VECO)</h2>



<div><img width="300" height="165" src="https://investorplace.com/wp-content/uploads/2018/08/nanotechmsn-300x165.jpg" alt=""><div>Source: Shutterstock</div></div>For a relatively low-risk investment in nanotechnology, I like Veeco Instruments (NASDAQ:<a href="https://investorplace.com/stock-quotes/veco-stock-quote/">VECO</a>). The company has concentrated on advanced semiconductor process equipment and thus enjoys a <a href="https://ir.veeco.com/financial-information/quarterly-financial-results/default.aspx">vanguard position</a> in nanoscale manufacturing. This shows in its ability to generate revenue and earnings growth during periods of cyclical industry decline.&nbsp;



What stands out is that Veeco is the market leader in many aspects, including laser spike annealing, where they have more than 70 percent market share. Their entry into new and developing markets like nanosecond annealing and ion beam deposition for low-resistance metals puts them in a very strategic place for the future of the next generation of chip production.



Despite being tethered to the volatile semiconductor industry, VECO has shown some resilience that may reduce its risk profile. The company&rsquo;s balance sheet is one of its greatest strengths, with current and quick ratios of 3 and 1.7, respectively. It also has a relatively low beta for a cyclical stock, 1.22, which it has maintained over the last five years.



<h2>DuPont de Nemours (DD)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/12/dupont1600-300x169.jpg" alt="The logo for DuPont (DD)."><div>Source: ricochet64 / Shutterstock.com</div></div>DuPont de Nemours (NYSE:<a href="https://investorplace.com/stock-quotes/dd-stock-quote/">DD</a>) is heavily invested in nanotechnology across various sectors.



The company&rsquo;s specialty in advanced materials and chemicals, especially in its Electronics &amp; Industrial business line, places it strategically in the nanotech field.



I want to point at DuPont&rsquo;s ability to recover and transform its business in the face of challenges as the most inspiring aspect. Still, the company has continued to pay a dividend and has even <a href="https://www.investors.dupont.com/news-and-media/press-release-details/2024/DuPont-Reports-First-Quarter-2024-Results/default.aspx">enhanced</a> free cash flow despite the current <a href="https://www.voanews.com/a/imf-predicts-china-economy-slowing-over-next-four-years/7468960.html">hardships</a> faced by a declining Chinese economy.



Furthermore, I welcome the change in DuPont&rsquo;s strategy. The company will be divided into three separate entities. This could open up quite a bit of value by forming more focused, nimble businesses that can take advantage of market opportunities. The company has a good balance sheet and stable cash flow, which will support this transition.&nbsp;



With around 24,000 employees, DD stock will be split into smaller units to reduce its execution and business risks. This transition will gradually unlock value for shareholders over time.



On the date of publication, Matthew Farley did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed are those of the writer, subject to the InvestorPlace.com <a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.
<div>Matthew started writing coverage of the financial markets during the crypto boom of 2017 and was also a team member of several fintech startups. He then started writing about Australian and U.S. equities for various publications. His work has appeared in MarketBeat, FXStreet, Cryptoslate, Seeking Alpha, and the New Scientist magazine, among others.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>
The post <a href="https://investorplace.com/2024/07/3-nanotechnology-stocks-with-microscopic-risk/">3 Nanotechnology Stocks With Microscopic Risk</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

3 Nanotechnology Stocks With Microscopic Risk

AAPL

AEIS

AMKR

ARIS

ATKR

ATOM

AVDL

BPMC

BRKR

BWBBP

CCOI

COHU

ENVX

EVTC

FRPT

GCMG

GENI

GWRE

HDSN

IRTC

KLAC

LLAP

LMNR

LUNA

MDYG

MLTX

NVMI

NYCB

PACS

PERI

QNST

RXST

STMEF

TRNS

VKTX

ZETA

Press Releases

Veeco Announces Upcoming Investor Event

General

Veeco Updates Fourth Quarter 2023 Guidance and Provides Initial 2024 Outlook

Veeco Announces Date for Fourth Quarter and Full-Year 2023 Financial Results and Conference Call

Veeco Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Veeco Releases Sustainability Report Highlighting  Progress and Dedication to ESG Goals

Veeco Announces Date for First Quarter Financial Results and Conference Call

Contracts

Leading Edge Semiconductor Company Places Multi-System Laser Annealing Order Including First Nanosecond Annealing System

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

Veeco Instruments

Veeco Instruments (VECO) Forecast

Veeco Instruments (NASDAQ:VECO) Stock, Quote.Headers.trade-ideas